HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

The hydroxychloroquine debate: a therapeutic dilemma for general practitioners

Abstract : France has been at the epicenter of the worldwide debate about hydroxychloroquine, as the main advocacy for its use to treat COVID-19 comes from a research unit led by Didier Raoult in Marseille. Among a national panel of 2940 general practitioners, we found that physicians in the areas most strongly affected by the epidemic or closest to the epicenter of the controversy reported that the hydroxychloroquine debate had made it difficult for them to deal with patients' treatment requests. Their adherence to official recommendations was also lower. It will be necessary to examine the conditions producing so strong a conflict.
Complete list of metadata

Contributor : Isabelle Combe Connect in order to contact the contributor
Submitted on : Monday, September 6, 2021 - 9:49:56 AM
Last modification on : Friday, February 4, 2022 - 3:27:34 AM
Long-term archiving on: : Tuesday, December 7, 2021 - 6:17:38 PM


Files produced by the author(s)




Romain Lutaud, Dimiti Scronias, Jeremy K Ward, Pierre Verger. The hydroxychloroquine debate: a therapeutic dilemma for general practitioners. European Journal of Public Health, Oxford University Press (OUP): Policy B - Oxford Open Option D, 2021, 31 (2), pp.283-285. ⟨10.1093/eurpub/ckab002⟩. ⟨hal-03334318⟩



Record views


Files downloads